IGM Biosciences (IGMS) Earnings Date & Reports

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IGMS is expected to report earnings to fall 70.15% to -25 cents per share on August 11

IGM Biosciences IGMS Stock Earnings Reports

Q2'25

Est.

$-0.26

Q1'25

Missed

by $0.51

Q4'24

Beat

by $0.13

Q3'24

Missed

by $0.21

Q2'24

Missed

by $0.75

The last earnings report on May 29 showed earnings per share of -86 cents, missing the estimate of -35 cents. With 214.40K shares outstanding, the current market capitalization sits at 77.55M.

View a ticker or compare two or three

Compare

IGMS